GDC-0927 Uses, Dosage, Side Effects and more
GDC-0927 is under investigation in clinical trial NCT02316509 (A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer).
| Trade Name | GDC-0927 |
| Generic | GDC-0927 |
| Type | |
| Formula | C28H28FNO4 |
| Weight | Average: 461.533 Monoisotopic: 461.200236549 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
